{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:22:13Z","timestamp":1784204533007,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Ministry for Health, Welfare and Family Affairs Republic of Korea","award":["A102065"],"award-info":[{"award-number":["A102065"]}]},{"name":"City of Seoul","award":["#10920"],"award-info":[{"award-number":["#10920"]}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["No. K20902001448-10E0100-03010"],"award-info":[{"award-number":["No. K20902001448-10E0100-03010"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1650-8","type":"journal-article","created":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T01:39:58Z","timestamp":1468546798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis"],"prefix":"10.1186","volume":"16","author":[{"given":"Young Kyung","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang Wook","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Youl","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Seop","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Suk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Yeol","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Chang","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ju","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol-In","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Soon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eu Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Sook","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong Ran","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8435-935X","authenticated-orcid":false,"given":"Min Ja","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,15]]},"reference":[{"key":"1650_CR1","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1128\/JCM.00376-11","volume":"49","author":"AR Marra","year":"2011","unstructured":"Marra AR, Camargo LF, Pignatari AC, Sukiennik T, Behar PR, Medeiros EA, et al. Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol. 2011;49:1866\u201371.","journal-title":"J Clin Microbiol."},{"key":"1650_CR2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","volume":"39","author":"H Wisplinghoff","year":"2004","unstructured":"Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309\u201317.","journal-title":"Clin Infect Dis."},{"key":"1650_CR3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2334-12-104","volume":"12","author":"RG Hall 2nd","year":"2012","unstructured":"Hall 2nd RG, Giuliano CA, Haase KK, Hazlewood KA, Frei CR, Forcade NA, et al. Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study. BMC Infect Dis. 2012;12:104.","journal-title":"BMC Infect Dis."},{"key":"1650_CR4","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1086\/421092","volume":"38","author":"PA Moise-Broder","year":"2004","unstructured":"Moise-Broder PA, Sakoulas G, Eliopoulos GM, Schentag JJ, Forrest A, Moellering Jr RC. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin Infect Dis. 2004;38:1700\u20135.","journal-title":"Clin Infect Dis."},{"key":"1650_CR5","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/jac\/dkr301","volume":"66","author":"CJ Walraven","year":"2011","unstructured":"Walraven CJ, North MS, Marr-Lyon L, Deming P, Sakoulas G, Mercier RC. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2011;66:2386\u201392.","journal-title":"J Antimicrob Chemother."},{"key":"1650_CR6","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/jac\/dks128","volume":"67","author":"L Rojas","year":"2012","unstructured":"Rojas L, Bunsow E, Mu\u00f1oz P, Cercenado E, Rodr\u00edguez-Cr\u00e9ixems M, et al. Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients. J Antimicrob Chemother. 2012;67:1760\u20138.","journal-title":"J Antimicrob Chemother."},{"key":"1650_CR7","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/jac\/dkq188","volume":"65","author":"SH Lin","year":"2010","unstructured":"Lin SH, Liao WH, Lai CC, Liao CH, Tan CK, Wang CY, et al. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan. J Antimicrob Chemother. 2010;65:1792\u20138.","journal-title":"J Antimicrob Chemother."},{"key":"1650_CR8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijantimicag.2008.04.011","volume":"32","author":"CH Liao","year":"2008","unstructured":"Liao CH, Chen SY, Huang YT, Hsueh PR. Outcome of patients with methicillin-resistant Staphylococcus aureus bacteraemia at an Emergency Department of a medical centre in Taiwan. Int J Antimicrob Agents. 2008;32:326\u201332.","journal-title":"Int J Antimicrob Agents."},{"key":"1650_CR9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1471-2334-10-159","volume":"10","author":"JL Wang","year":"2010","unstructured":"Wang JL, Wang JT, Sheng WH, Chen YC, Chang SC. Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC\u2009=\u20092\u00a0mg\/L, by the broth microdilution method. BMC Infect Dis. 2010;10:159.","journal-title":"BMC Infect Dis."},{"key":"1650_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10096-007-0272-x","volume":"26","author":"J G\u00f3mez","year":"2007","unstructured":"G\u00f3mez J, Garc\u00eda-V\u00e1zquez E, Ba\u00f1os R, Canteras M, Ruiz J, Ba\u00f1os V, et al. Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy. Eur J Clin Microbiol Infect Dis. 2007;26:239\u201345.","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"1650_CR11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jac\/dkl006","volume":"57","author":"CT Fang","year":"2006","unstructured":"Fang CT, Shau WY, Hsueh PR, Chen YC, Wang JT, Hung CC, et al. Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome. J Antimicrob Chemother. 2006;57:511\u20139.","journal-title":"J Antimicrob Chemother."},{"key":"1650_CR12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1469-0691.2009.02934.x","volume":"16","author":"D Marchaim","year":"2010","unstructured":"Marchaim D, Kaye KS, Fowler VG, Anderson DJ, Chawla V, Golan Y, et al. Case\u2013control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2010;16:747\u201352.","journal-title":"Clin Microbiol Infect."},{"key":"1650_CR13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jinf.2008.11.003","volume":"58","author":"J Rodr\u00edguez-Ba\u00f1o","year":"2009","unstructured":"Rodr\u00edguez-Ba\u00f1o J, Mill\u00e1n AB, Dom\u00ednguez MA, Borraz C, Gonz\u00e1lez MP, Almirante B, et al. Impact of inappropriate empirical therapy for sepsis due to health care-associated methicillin-resistant Staphylococcus aureus. J Infect. 2009;58:131\u20137.","journal-title":"J Infect."},{"key":"1650_CR14","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/01.CCM.0000227655.41566.3E","volume":"34","author":"GE Schramm","year":"2006","unstructured":"Schramm GE, Johnson JA, Doherty JA, Micek ST, Kollef MH. Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment. Crit Care Med. 2006;34:2069\u201374.","journal-title":"Crit Care Med."},{"key":"1650_CR15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","volume":"46","author":"A Soriano","year":"2008","unstructured":"Soriano A, Marco F, Mart\u00ednez JA, Pisos E, Almela M, Dimova VP, et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2008;46:193\u2013200.","journal-title":"Clin Infect Dis."},{"key":"1650_CR16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10096-006-0096-0","volume":"25","author":"R Khatib","year":"2006","unstructured":"Khatib R, Saeed S, Sharma M, Riederer K, Fakih MG, Johnson LB. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis. 2006;25:181\u20135.","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"1650_CR17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/519283","volume":"45","author":"JC McGregor","year":"2007","unstructured":"McGregor JC, Rich SE, Harris AD, Perencevich EN, Osih R, Lodise Jr TP, et al. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis. 2007;45:329\u201337.","journal-title":"Clin Infect Dis."},{"key":"1650_CR18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/CMR.05022-11","volume":"25","author":"SJ Hal van","year":"2012","unstructured":"van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev. 2012;25:362\u201386.","journal-title":"Clin Microbiol Rev."},{"key":"1650_CR19","doi-asserted-by":"crossref","first-page":"457435","DOI":"10.1155\/2013\/457435","volume":"2013","author":"CH Lee","year":"2013","unstructured":"Lee CH, Chien CC, Liu JW. Timing of initiating glycopeptide therapy for methicillin-Resistant Staphylococcus aureus bacteremia: the impact on clinical outcome. Scientific World Journal. 2013;2013:457435.","journal-title":"Scientific World Journal."},{"key":"1650_CR20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jac\/dkh366","volume":"54","author":"SH Kim","year":"2004","unstructured":"Kim SH, Park WB, Lee KD, Kang CI, Bang JW, Kim HB, et al. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2004;54:489\u201397.","journal-title":"J Antimicrob Chemother."},{"key":"1650_CR21","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1093\/jac\/dkq373","volume":"65","author":"M Paul","year":"2010","unstructured":"Paul M, Kariv G, Goldberg E, Raskin M, Shaked H, Hazzan R, et al. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2010;65:2658\u201365.","journal-title":"J Antimicrob Chemother."},{"key":"1650_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O\u2019Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1\u201345.","journal-title":"Clin Infect Dis."},{"key":"1650_CR23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309\u201332.","journal-title":"Am J Infect Control."},{"key":"1650_CR24","volume-title":"Harrison\u2019s principles of Internal Medicine (ed 18)","author":"DL Longo","year":"2008","unstructured":"Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Joseph L. Harrison\u2019s principles of Internal Medicine (ed 18). USA: Mc Graw Hill; 2008."},{"key":"1650_CR25","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245\u201351.","journal-title":"J Clin Epidemiol."},{"key":"1650_CR26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818\u201329.","journal-title":"Crit Care Med."},{"key":"1650_CR27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-115-8-585","volume":"115","author":"JW Chow","year":"1991","unstructured":"Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med. 1991;115:585\u201390.","journal-title":"Ann Intern Med."},{"key":"1650_CR28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00064","volume":"127","author":"DB Rubin","year":"1997","unstructured":"Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757\u201363.","journal-title":"Ann Intern Med."},{"key":"1650_CR29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7326\/0003-4819-137-8-200210150-00015","volume":"137","author":"LE Braitman","year":"2002","unstructured":"Braitman LE, Rosenbaum PR. Rare outcomes, common treatments: analytic strategies using propensity scores. Ann Intern Med. 2002;137:693\u20135.","journal-title":"Ann Intern Med."},{"key":"1650_CR30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46:399\u2013424.","journal-title":"Multivariate Behav Res."},{"key":"1650_CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/pst.365","volume":"9","author":"M Sugihara","year":"2010","unstructured":"Sugihara M. Survival analysis using inverse probability of treatment weighted methods based on the generalized propensity score. Pharm Stat. 2010;9:21\u201334.","journal-title":"Pharm Stat."},{"key":"1650_CR32","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4419-1213-8","volume-title":"Design of Observational Studies","author":"PR Rosenbaum","year":"2010","unstructured":"Rosenbaum PR. Design of Observational Studies. New York: Springer; 2010."},{"key":"1650_CR33","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10464-013-9604-4","volume":"52","author":"ST Lanza","year":"2013","unstructured":"Lanza ST, Moore JE, Butera NM. Drawing causal inferences using propensity scores: a practical guide for community psychologists. Am J Community Psychol. 2013;52:380\u201392.","journal-title":"Am J Community Psychol."},{"key":"1650_CR34","doi-asserted-by":"crossref","first-page":"e11432","DOI":"10.1371\/journal.pone.0011432","volume":"5","author":"ML Schweizer","year":"2010","unstructured":"Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, et al. Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study. PLoS One. 2010;5:e11432.","journal-title":"PLoS One."},{"key":"1650_CR35","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.ijid.2010.09.013","volume":"15","author":"T Lewis","year":"2011","unstructured":"Lewis T, Chaudhry R, Nightingale P, Lambert P, Das I. Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK. Int J Infect Dis. 2011;15:e131\u20135.","journal-title":"Int J Infect Dis."},{"key":"1650_CR36","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1086\/375057","volume":"36","author":"TP Lodise","year":"2003","unstructured":"Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis. 2003;36:1418\u201323.","journal-title":"Clin Infect Dis."},{"key":"1650_CR37","first-page":"223","volume":"24","author":"JS Kim","year":"2004","unstructured":"Kim JS, Kim HS, Song W, Cho HC, Lee KM, Kim EC. Antimicrobial resistance profiles of Staphylococcus aureus isolated in 13 Korean hospitals. Korean J Lab Med. 2004;24:223\u20139.","journal-title":"Korean J Lab Med."},{"key":"1650_CR38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0924-8579(94)00036-T","volume":"5","author":"A Voss","year":"1995","unstructured":"Voss A, Doebbeling BN. The worldwide prevalence of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 1995;5:101\u20136.","journal-title":"Int J Antimicrob Agents."},{"key":"1650_CR39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10156-010-0086-0","volume":"17","author":"Y Takesue","year":"2011","unstructured":"Takesue Y, Nakajima K, Takahashi Y, Ichiki K, Ishihara M, Wada Y, et al. Clinical characteristics of vancomycin minimum inhibitory concentration of 2\u00a0\u03bcg\/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia. J Infect Chemother. 2011;17:52\u20137.","journal-title":"J Infect Chemother."},{"key":"1650_CR40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/598622","volume":"29","author":"R Feld","year":"1999","unstructured":"Feld R. Vancomycin as part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancer: pros and cons. Clin Infect Dis. 1999;29:503\u20137.","journal-title":"Clin Infect Dis."},{"key":"1650_CR41","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/377534","volume":"37","author":"VL Yu","year":"2003","unstructured":"Yu VL, Chiou CC, Feldman C, Ortqvist A, Rello J, Morris AJ, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis. 2003;37:230\u20137.","journal-title":"Clin Infect Dis."},{"key":"1650_CR42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1473-3099(05)70164-X","volume":"5","author":"KZ Vardakas","year":"2005","unstructured":"Vardakas KZ, Samonis G, Chrysanthopoulou SA, Bliziotis IA, Falagas ME. Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a meta-analysis of randomised controlled trials. Lancet Infect Dis. 2005;5:431\u20139.","journal-title":"Lancet Infect Dis."},{"key":"1650_CR43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/jac\/dki028","volume":"55","author":"M Paul","year":"2005","unstructured":"Paul M, Borok S, Fraser A, Vidal L, Leibovici L. Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2005;55:436\u201344.","journal-title":"J Antimicrob Chemother."},{"key":"1650_CR44","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJM198608283150905","volume":"315","author":"PA Pizzo","year":"1986","unstructured":"Pizzo PA, Hathorn JW, Hiemenz J, Browne M, Commers J, Cotton D, et al. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med. 1986;315:552\u20138.","journal-title":"N Engl J Med."},{"key":"1650_CR45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/0003-4819-108-1-30","volume":"108","author":"M Rubin","year":"1988","unstructured":"Rubin M, Hathorn JW, Marshall D, Gress J, Steinberg SM, Pizzo PA. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann Intern Med. 1988;108:30\u20135.","journal-title":"Ann Intern Med."},{"key":"1650_CR46","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.ijid.2012.08.005","volume":"17","author":"JT Jacob","year":"2013","unstructured":"Jacob JT, DiazGranados CA. High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis. Int J Infect Dis. 2013;17:e93\u2013e100.","journal-title":"Int J Infect Dis."},{"key":"1650_CR47","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ijantimicag.2012.07.023","volume":"40","author":"MN Mavros","year":"2012","unstructured":"Mavros MN, Tansarli GS, Vardakas KZ, Rafailidis PI, Karageorgopoulos DE, Falagas ME. Impact of vancomycin minimum inhibitory concentration on clinical outcomes of patients with vancomycin-susceptible Staphylococcus aureus infections: a meta-analysis and meta-regression. Int J Antimicrob Agents. 2012;40:496\u2013509.","journal-title":"Int J Antimicrob Agents."},{"key":"1650_CR48","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/cid\/cir118","volume":"52","author":"AS Lubin","year":"2011","unstructured":"Lubin AS, Snydman DR, Ruthazer R, Bide P, Golan Y. Predicting high vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus bloodstream infections. Clin Infect Dis. 2011;52:997\u20131002.","journal-title":"Clin Infect Dis."},{"key":"1650_CR49","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1128\/JCM.01158-12","volume":"50","author":"F Ludwig","year":"2012","unstructured":"Ludwig F, Edwards B, Lawes T, Gould IM. Effects of storage on vancomycin and daptomycin MIC in susceptible blood isolates of methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2012;50:3383\u20137.","journal-title":"J Clin Microbiol."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1650-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T01:16:22Z","timestamp":1748999782000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1650-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,15]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1650"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1650-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,15]]},"article-number":"331"}}